Armistice Capital, LLC Adamas Pharmaceuticals, Inc. Call Options Transaction History

Armistice Capital, LLC

  • $5.71 Billion
  • Q2 2025

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2017

Feb 14, 2018
SELL
N/A
-26,000 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
N/A
26,000
26,000 $550,000

About Adamas Pharmaceuticals, Inc.

ADMS Quotes by TradingView
  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email